A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT05357755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Oral Tablet Formulation of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the efficacy of an oral tablet formulation of JNJ-77242113 compared with placebo in participants with moderate-to-severe plaque psoriasis.
Study identification
- NCT ID
- NCT05357755
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2022
- Primary completion
- Mar 22, 2023
- Completion
- Apr 9, 2023
- Last update posted
- May 4, 2026
2022 – 2023
United States locations
- U.S. sites
- 12
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stoll Dermatology | Beverly Hills | California | 90212 | — |
| Northshore University Healthsystem | Skokie | Illinois | 60077 | — |
| Epiphany Dermatology of Kansas, LLC | Overland Park | Kansas | 66210 | — |
| Dermatology Specialists | Louisville | Kentucky | 40241 | — |
| Lawrence J Green MD LLC | Rockville | Maryland | 20850 | — |
| ActivMed Practices and Research | Beverly | Massachusetts | 01915 | — |
| ActivMed Practices and Research | Portsmouth | New Hampshire | 03801 | — |
| Windsor Dermatology, PC | East Windsor | New Jersey | 08520 | — |
| Unity Clinical Research | Oklahoma City | Oklahoma | 73118 | — |
| The Pennsylvania Centre for Dermatology, LLC | Exton | Pennsylvania | 19341 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05357755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05357755 live on ClinicalTrials.gov.